NCT06988124View on ClinicalTrials.gov

Dexamethasone Palmitate for PONV After Craniotomy

NARecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

June 25, 2025

Primary Completion Date

May 1, 2027

Study Completion Date

June 1, 2027

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

Dexamethasone Palmitate

Patients in the dexamethasone palmitate group will be assigned to receive intravenous injection of dexamethasone palmitate 8 mg (contains 5mg dexamethasone) after anesthesia induction and before surgical incision.

DRUG

Dexamethasone

Patients in the dexamethasone group will be assigned to receive intravenous injections of dexamethasone 5 mg after anesthesia induction and before surgical incision.

Trial Locations (1)

100050

RECRUITING

Fang Luo, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT06988124 - Dexamethasone Palmitate for PONV After Craniotomy | Biotech Hunter | Biotech Hunter